Loading…
CIK 0002013410 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("fcpm-iii-services-b-v","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AURA BIOSCIENCES INC | COM | $28.8M | 3.8% | 4,053,775 SH | New |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | $14.7M | 2.0%Prev: 6.5% | 3,468,430 SH | Decreased+16,100 SH |
| CRESCENT BIOPHARMA INC. | COM | $30.2M | 4.0% | 1,677,852 SH | New |
| DAMORA THERAPEUTICS INC | COM NEW | $63.5M | 8.5% | 2,441,000 SH | New |
| DYNE THERAPEUTICS INC | COM | $85.5M | 11.4%Prev: 14.1% | 3,848,256 SH | Increased-1,614,590 SH |
| ENGENE HOLDINGS INC | COM | $16.7M | 2.2%Prev: 9.5% | 9,632,561 SH | Decreased |
| ENGENE HOLDINGS INC | W EXP 10/31/2028 | $834K | 0.1%Prev: 0.6% | 2,878,148 SH | Decreased |
| MAPLIGHT THERAPEUTICS INC | COM | $115.6M | 15.4% | 3,226,400 SH | New |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $287.7M | 38.3%Prev: 52.2% | 8,490,353 SH | Increased-2,141,760 SH |
| REPLIMUNE GROUP INC | COM | $31.1M | 4.1%Prev: 9.8% | 2,808,368 SH | Decreased-1,101,328 SH |
| VOR BIOPHARMA INC | COM NEW | $75.8M | 10.1% | 4,117,354 SH | New |
| 13F-HR |
| 0001193125-26-350207 |
| $750.4M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000950123-25-008060 | $369.2M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001193125-26-225423 | $722.2M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000950123-25-005517 | $413.7M | View |